Fresh analysis indicates that patients who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who stop traditional lifestyle plans.
Published data in a major medical journal points out that while obese people frequently drop substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month after stopping.
"Users buying these treatments should be informed of the risk of rapid rebound weight gain when the therapy is stopped," warns expert Dr. Susan Jebb.
This pace of recovery means a reversion to starting mass in about a year and a half.
Analyzing Treatments
The study, which reviewed dozens of studies involving thousands of participants, contrasted the results of the injectable medications with conventional dieting.
Scientists emphasize that individuals who shed pounds through dieting generally see a more gradual creep back—around 0.1 kg a month—after stopping.
The Reason for the Fast Regain
Doctors suggest the mechanism of the injections explains the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal might result in the body to produce less of its endogenous hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' means hunger is no longer kept in check, making binge eating far more likely."
An Ongoing Disease?
Health authorities recommend the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians contend that, given the likelihood of weight regain, the treatment is often life-long.
This opinion is echoed by pharmaceutical companies, who note that the results "emphasize the chronic nature of excess weight," akin to managing conditions like hypertension.
User Accounts
People who have come off the jabs explain a powerful return of cravings.
"I experienced a switch activating and you become extremely hungry," recalled an individual.
This challenge is exacerbated if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Figures suggest that a significant number of adults in the UK have used these injections in the past year, with demand being substantial.
- Adoption is more common among females than men.
- The middle-aged age group shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on combined behavioural management.